Holen Sie sich die Stockscreener-App
0.6181
13.37%
0.0532
Schlusskurs vom Vortag:
$0.5649
Offen:
$0.57
24-Stunden-Volumen:
298.08K
Relative Volume:
1.71
Marktkapitalisierung:
$27.92M
Einnahmen:
$80.28M
Nettoeinkommen (Verlust:
$-38.83M
KGV:
-0.7431
EPS:
-0.8318
Netto-Cashflow:
$-28.67M
1W Leistung:
-15.88%
1M Leistung:
-26.23%
6M Leistung:
-57.02%
1J Leistung:
-47.51%
1-Tages-Spanne:
$0.57
$0.68
1-Wochen-Bereich:
$0.544
$0.822
52-Wochen-Spanne:
$0.544
$2.20
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.6241 | 25.27M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
102.54 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.84 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.53 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.49 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
79.96 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
Aug Fed Impact: Is TELA Bio Inc a stock for growth or value investors2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn
Q3 2025 TELA Bio Inc Earnings Call Transcript - gurufocus.com
Citizens Jmp Issues Pessimistic Forecast for TELA Bio (NASDAQ:TELA) Stock Price - Defense World
Published on: 2026-03-28 00:22:27 - baoquankhu1.vn
TELA Bio, Inc.Common stock - FinancialContent
TELA Bio analysts cut their forecasts after Q4 results - msn.com
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 earnings call transcript - MSN
Citizens cuts Tela Bio stock price target on commercial transition By Investing.com - za.investing.com
Citizens cuts Tela Bio stock price target on commercial transition - Investing.com UK
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation - MSN
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $2.00 - Defense World
TELA Bio, Inc. (TELA) reports Q4 loss, lags revenue estimates - MSN
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), TELA Bio (TELA) and Nuvalent (NUVL) - The Globe and Mail
EPS Watch: What analysts say about TELA Bio Inc stock2026 Volatility Report & Consistent Income Trade Ideas - baoquankhu1.vn
TELA Bio (NASDAQ:TELA) Given New $1.00 Price Target at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital - Defense World
TELA Bio Analysts Cut Their Forecasts After Q4 Results - Benzinga
Patterns Watch: Is TELA Bio Inc showing insider buyingWeekly Profit Analysis & Consistent Profit Trade Alerts - baoquankhu1.vn
TELA Bio 10-K: Revenue $80.3M, Net Loss $38.8M - TradingView
TELA Bio (NASDAQ: TELA) grows 2025 revenue 16% while investing heavily in R&D - Stock Titan
Piper Sandler Lowers Price Target for TELA Bio (TELA) to $1.00 | - gurufocus.com
TELA Bio net loss hits USD 9M in Q4 2025 - Medical Buyer
TELA Bio (TELA) Rating Maintained but Price Target Lowered by An - gurufocus.com
Piper Sandler cuts TELA Bio stock price target on lowered outlook - Investing.com Canada
Analyst Maintains 'Buy' Rating for TELA, Lowers Price Target to $2.00 | TELA Stock News - gurufocus.com
Jefferies cuts TELA Bio stock price target on slower growth outlook - Investing.com UK
TELA Bio, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call Transcript - Insider Monkey
Jefferies cuts TELA Bio stock price target on slower growth outlook By Investing.com - Investing.com South Africa
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Rev - GuruFocus
Tela Bio Earnings Call: Growth Momentum, Cautious Outlook - TipRanks
TELA Bio, Inc. (TELA) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
TELA Bio (TELA) Q4 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: TELA Bio Q4 2025 surprises with EPS beat but revenue miss - Investing.com
TelaBio (TELA) Reports Record Quarterly Revenue in Q4 - gurufocus.com
TELA Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TELA Bio Q4 Net Loss Narrows, Revenue Rises - marketscreener.com
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates - ChartMill
TELA Sees Growth with FY26 Revenue Projected to Rise at Least 8% - gurufocus.com
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
TELA Bio Posts Record 2025 Revenue, Sets 2026 Outlook - TipRanks
TELA BIO ($TELA) Releases Q4 2025 Earnings - quiverquant.com
Q4 2025 TELA Bio Inc Earnings Call Transcript - gurufocus.com
TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
TELA Bio (NASDAQ: TELA) lifts 2025 sales 16% but posts $38.8M loss - Stock Titan
TELA Bio, Inc. Provides Revenue Guidance for the First Quarter 2026 and Full Year 2026 - marketscreener.com
TELA Bio Inc (TELA) Q4 2025: Everything You Need To Know Ahead O - gurufocus.com
If You Invested $1,000 in Tela Bio, Inc. (TELA) - Stock Titan
TELA Bio Awards Inducement Equity Grants to New Employees - MSN
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):